Literature DB >> 23902885

[Relationship between dynamic contrast-enhanced and perfusion magnetic resonance imaging and T-staging of nasopharyngeal carcinoma].

Zhong Yang1, Jian-min Xu, Jing-shan Gong, Jie Ma, Jiang-bo Yu, Shao-peng Zhou.   

Abstract

OBJECTIVE: To perform the dynamic contrast-enhanced and perfusion magnetic resonance imaging (MRI) of nasopharyngeal carcinoma (NPC) and analyze the correlation with T-staging.
METHODS: A total of 46 naïve NPC patients underwent MRI. The parameters of dynamic contrast-enhanced and perfusion MRI included time to peak (TTP), Slopemax and area under the curve (AUC).
RESULTS: The increasing period of signal intensity-time curve of all cases was steep. And the perfusion image of AUC could reflect the blood perfusion of tumor tissue. Parameters (TTP/Slopemax/AUC) in different T-staging were T1-staging (60.45/10.59/20 619.56), T2-staging (58.12/12.47/23 037.23), T3-staging (70.61/15.06/26 507.23) and T4-staging (41.72/19.87/30 092.27). Their statistical results were r = -0.247, P > 0.05 and r = 0.859, P < 0.050 and r = 0.963, P < 0.05 respectively. And statistical significance existed in Slopemax, AUC with T-staging.
CONCLUSION: Dynamic contrast-enhanced and perfusion MRI can reflect angiogenesis of NPC. And there is a positive correlation between the parameters of dynamic contrast-enhanced and perfusion MRI (Slopemax, AUC) and T-staging.

Entities:  

Mesh:

Year:  2013        PMID: 23902885

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  2 in total

1.  M1 stage subdivision and treatment outcome of patients with bone-only metastasis of nasopharyngeal carcinoma.

Authors:  Lujun Shen; Jun Dong; Sheng Li; Yue Wang; Annan Dong; Wanhong Shu; Ming Wu; Changchuan Pan; Yunfei Xia; Peihong Wu
Journal:  Oncologist       Date:  2015-02-06

2.  Subdivision of M category for nasopharyngeal carcinoma with synchronous metastasis: time to expand the M categorization system.

Authors:  Lu-Jun Shen; Si-Yang Wang; Guo-Feng Xie; Qi Zeng; Chen Chen; An-Nan Dong; Zhi-Mei Huang; Chang-Chuan Pan; Yun-Fei Xia; Pei-Hong Wu
Journal:  Chin J Cancer       Date:  2015-08-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.